Amylmetacresol + Lignocaine
Uses of Amylmetacresol + Lignocaine
Amylmetacresol + Lignocaine helps relieve sore throat symptoms which includes soreness and swelling of the throat.
How Amylmetacresol + Lignocaine Works
Flurbiprofen is a NSAID which works by changing the body’s response to pain, swelling, and high temperature.
Side Effects of Amylmetacresol + Lignocaine
Dizziness, Headache, Throat Irritation, Mouth Ulcers Or Pain In The Mouth, Throat Pain, Nausea And Diarrhea, Itching Sensation In Skin , Drowsiness, Blistering In The Mouth Or Throat, Numbness In The Throat, Bloating Of The Stomach, Pain In The Abdomen, Wind, Constipation, Indigestion, Vomiting, Dry Mouth, Burning Sensation In The Mouth, Skin Rashes, Itchy Skin.
Warnings
Kidney Safe If Prescribed
Amylmetacresol + Lignocaine is generally safe to be used in patients with kidney disease. There's minimal systemic absorption of Amylmetacresol + Lignocaine.
Alcohol Safe
It is generally safe to consume alcohol with Amylmetacresol + Lignocaine. Taking Amylmetacresol + Lignocaine with alcohol has no known interactions.
Pregnancy Limited Data
There are no or limited amount of data from the use of Amylmetacresol + Lignocaine during pregnancy. As with all medicines care should be taken when using this product in pregnancy and seek advice from your doctor or pharmacist before starting.
Driving Generally Safe
Amylmetacresol + Lignocaine should not affect alertness or driving ability.
Liver Safe If Prescribed
Amylmetacresol + Lignocaine is safe to be used in patients with liver disease. There's minimal systemic absorption of Amylmetacresol + Lignocaine.
Lactation Limited Data
There are no or limited amount of data from the use of Amylmetacresol + Lignocaine during lactation. As with all medicines care should be taken when using this product in pregnancy and seek advice from your doctor or pharmacist before starting.
Written by Dr Sri Viknarajan, MD (Universiti Hasanuddin, Indonesia)
Reviewed by Dr Nur Syuhada binti Zulkifli, MD, Universiti Kebangsaan Malaysia (UKM).
